# An Evaluation of the Safety and Pharmacokinetics of Tavaborole Topical Solution for the Treatment of Fungal Disease of the Toenail in Children and Adolescents

> **NCT03405818** · PHASE4 · COMPLETED · sponsor: **Pfizer** · enrollment: 55 (actual)

## Conditions studied

- Onychomycosis
- Tinea Unguium

## Interventions

- **DRUG:** Tavaborole 5% Topical Solution

## Key facts

- **NCT ID:** NCT03405818
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-22
- **Primary completion:** 2017-07-27
- **Final completion:** 2017-07-27
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2018-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03405818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03405818, "An Evaluation of the Safety and Pharmacokinetics of Tavaborole Topical Solution for the Treatment of Fungal Disease of the Toenail in Children and Adolescents". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03405818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*